MUSTAFA RAWAF: Open Payments
NPI 1114241973 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,118 in 40 payments from 2 companies in 2025. Trend: 2023 $36,400 · 2024 $33,720 · 2025 $41,118
Speaker / faculty: $34,844Travel & lodging: $3,133Consulting: $1,876Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 39 | $40,988 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $130 |
Products named: ABILIFY MAINTENA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across NV — which companies pay providers there.
